In this regard some clinical studies suggest that circulating AdipoQ inhibit tumor cell proliferation by decreasing AKT and beta catenin levels across multiple malignancies (breast, colon and prostate) [56, 57]. The gene discussed is AKT1; the disease is neoplasm.